NCT00023075View on ClinicalTrials.gov

Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2001

Study Completion Date

August 31, 2003

Conditions

Primary Lateral SclerosisHereditary Spastic ParaplegiaAmyotrophic Lateral Sclerosis

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors

lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00023075 - Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter